hotspot -WSS

hotspot

author：knowledge 2025-09-03 12:07:15 - browse：72

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Medicare drug price negotiation continues, as pharma counteroffers

Wikipedia

WSS

Harvard's David Sinclair gets blowback over aging

Novavax promises a turnaround & Lilly roils the obesity market

Peter Hotez and the public health issue of online harassment

BioMarin wins approval for gene therapy to treat hemophilia A

Microsoft's Peter Lee: Generative AI could help doctors be more human

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

hotspot

hotspot

MORE: General Motors recalls over 600K cars due to car seat safety issue

focus

Medicare proposal to cover medical devices draws a mixed reaction

Fetal cell organoids grown from amniotic fluid, study finds

Virginia high school admissions case could be legal follow

Fetal cell organoids grown from amniotic fluid, study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Moonlake's readout produced a cash windfall. Risks remain

Wildfire smoke exposes gaps in outdoor worker protections

State of the Union pitch: Bigger Medicare drug price negotiations

Psychedelics group wrestles with new pharma identity

In Memoriam: Notable people who died in 2023

hotspot

IVF doctors demand details after CooperSurgical lawsuit

Stem cell biologist probes earliest stages of human development

BioMarin wins approval for gene therapy to treat hemophilia A

Families look for replacement for GSK asthma drug Flovent

Drug repurposing or repositioning? The language matters

Psychedelics group wrestles with new pharma identity

Wikipedia

focus

leisure time

focus